Psychopharmacology Flashcards
The movement of the drug into the bloodstream. With oral agents this typically occurs in the small intestines.
Absorption
The transformation or breakdown of the drug in preparation for elimination from the body.
Metabolism
Unintended and undesired effects that occur when the medication is administered correctly. The severity of the impact may be dose dependent.
Adverse effects
The process by which substances (drugs, substrates, toxins) leave the body (feces, urine, skin).
Excretion
The pre-circulation process (uptake and conversion) by which the substrates (changed drug) are significantly reduced by the cytochrome P450 (CYP450) enzyme in the liver after enteric absorption. Non-enteric routes of medication bypass first pass effect.
First Pass Effect
Disorganized behavior with accompanying (one of three of the following): delusions, hallucinations, and/or disorganized speech (marked by frequent derailment or incoherence) lasting <1 day.
Psychosis
The PMHNP is monitoring a serum drug level for a med with a 24-hour half-life. How many hours will it take to reach steady state?A. 48B. 72C. 96D. 120
D. 120 hours. Steady state is achieved in five half-lives of the medication. (5 x 24 = 120)
Rapidly diminishing responsiveness to increasing doses of the medication; aka “poop-out” effect.
Tachyphylaxis
Rare life-threatening condition that can occur at any time in a patient receiving antipsychotic medication. It most commonly occurs with typical versus atypical antipsychotics within the first 2 weeks of starting treatment.
Neuroleptic Malignant Syndrome
Absent movement; difficulty standing; flat affect; avolition. Often mistaken for disinterest.
Akinesia
A drug that blocks receptors, inhibiting a biological response, is known as a(n): A. Partial agonistB. Inverse agonist C. AntagonistD. Agonist
C. An antagonist is a medication that blocks a receptor to inhibit a biological response even from endogenous agnists.
Shuffling gait, motor slowing, masked flat facial expression, tremor, and cogwheel rigidity.
Pseudo-Parkinson’s
A usually undesired but foreseeable effect that occurs regardless of dose, and often resolves after continued therapy without intervention.
Side effect
Involuntary muscle spasms.
Dystonia
When target symptoms cease to be acceptably controlled or mitigated.
Treatment failure
Dietary (tyramine) restrictions (for this drug class):- Aged cheese- Cured meat- Smoked meat- Fermented foods- Fish sauce- Alcohol- Soy products
MAOIs (Mono-amine Oxidase Inhibitors)